Douglas Evan Godshall - Net Worth and Insider Trading

Douglas Evan Godshall Net Worth

The estimated net worth of Douglas Evan Godshall is at least $59 Million dollars as of 2024-11-05. Douglas Evan Godshall is the President & CEO of Shockwave Medical Inc and owns about 162,762 shares of Shockwave Medical Inc (SWAV) stock worth over $54 Million. Douglas Evan Godshall is the President & Chief Exec Officer of Heartware International Inc and owns about 84,345 shares of Heartware International Inc (HTWR) stock worth over $5 Million. Douglas Evan Godshall is also the Director of EyePoint Pharmaceuticals Inc and owns about 2,950 shares of EyePoint Pharmaceuticals Inc (EYPT) stock worth over $34,250. Besides these, Douglas Evan Godshall also holds Immunic Inc (IMUX) . Details can be seen in Douglas Evan Godshall's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Douglas Evan Godshall has not made any transactions after 2024-02-15 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Douglas Evan Godshall

To

Douglas Evan Godshall Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Douglas Evan Godshall owns 4 companies in total, including Shockwave Medical Inc (SWAV) , EyePoint Pharmaceuticals Inc (EYPT) , and Immunic Inc (IMUX) among others .

Click here to see the complete history of Douglas Evan Godshall’s form 4 insider trades.

Insider Ownership Summary of Douglas Evan Godshall

Ticker Comapny Transaction Date Type of Owner
SWAV Shockwave Medical Inc 2024-02-15 director & President & CEO
EYPT EyePoint Pharmaceuticals Inc 2019-03-29 director
IMUX Immunic Inc 2018-09-19 director
LIMIT LIMIT 2016-08-23 director & President & Chief Exec Officer

Douglas Evan Godshall Latest Holdings Summary

Douglas Evan Godshall currently owns a total of 4 stocks. Among these stocks, Douglas Evan Godshall owns 162,762 shares of Shockwave Medical Inc (SWAV) as of February 15, 2024, with a value of $54 Million and a weighting of 91.71%. Douglas Evan Godshall owns 84,345 shares of Heartware International Inc (HTWR) as of February 25, 2016, with a value of $5 Million and a weighting of 8.23%. Douglas Evan Godshall also owns 2,950 shares of EyePoint Pharmaceuticals Inc (EYPT) as of March 29, 2019, with a value of $34,250 and a weighting of 0.06%. The other 1 stocks Immunic Inc (IMUX) have a combined weighting of 0% among all his current holdings.

Latest Holdings of Douglas Evan Godshall

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
SWAV Shockwave Medical Inc 2024-02-15 162,762 334.75 54,484,580
HTWR Heartware International Inc 2016-02-25 84,345 57.98 4,890,323
EYPT EyePoint Pharmaceuticals Inc 2019-03-29 2,950 11.61 34,250
IMUX Immunic Inc 2018-09-19 0 1.20 0

Holding Weightings of Douglas Evan Godshall


Douglas Evan Godshall Form 4 Trading Tracker

According to the SEC Form 4 filings, Douglas Evan Godshall has made a total of 27 transactions in Shockwave Medical Inc (SWAV) over the past 5 years, including 0 buys and 27 sells. The most-recent trade in Shockwave Medical Inc is the sale of 10,000 shares on February 15, 2024, which brought Douglas Evan Godshall around $2 Million.

According to the SEC Form 4 filings, Douglas Evan Godshall has made a total of 0 transactions in Heartware International Inc (HTWR) over the past 5 years. The most-recent trade in Heartware International Inc is the sale of 1,990 shares on February 25, 2016, which brought Douglas Evan Godshall around $58,108.

According to the SEC Form 4 filings, Douglas Evan Godshall has made a total of 0 transactions in EyePoint Pharmaceuticals Inc (EYPT) over the past 5 years. The most-recent trade in EyePoint Pharmaceuticals Inc is the acquisition of 1,700 shares on March 29, 2019, which cost Douglas Evan Godshall around $29,750.

More details on Douglas Evan Godshall's insider transactions can be found in the Insider Trading History of Douglas Evan Godshall table.

Insider Trading History of Douglas Evan Godshall

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Douglas Evan Godshall Trading Performance

GuruFocus tracks the stock performance after each of Douglas Evan Godshall's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Douglas Evan Godshall is -8.38%. GuruFocus also compares Douglas Evan Godshall's trading performance to market benchmark return within the same time period. The performance of stocks bought by Douglas Evan Godshall within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Douglas Evan Godshall's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Douglas Evan Godshall

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
0 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 1.12 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) -2.71 LIMIT LIMIT LIMIT LIMIT LIMIT

Douglas Evan Godshall Ownership Network

Ownership Network List of Douglas Evan Godshall

No Data

Ownership Network Relation of Douglas Evan Godshall

Insider Network Chart

Douglas Evan Godshall Owned Company Details

What does Shockwave Medical Inc do?

Who are the key executives at Shockwave Medical Inc?

Douglas Evan Godshall is the director & President & CEO of Shockwave Medical Inc. Other key executives at Shockwave Medical Inc include Chief Commercial Officer Isaac Zacharias , VP & Finance Trinh Phung , and CFO & Secretary Dan Puckett .

Shockwave Medical Inc (SWAV) Insider Trades Summary

Over the past 18 months, Douglas Evan Godshall made 8 insider transaction in Shockwave Medical Inc (SWAV) with a net sale of 70,000. Other recent insider transactions involving Shockwave Medical Inc (SWAV) include a net sale of 44,000 shares made by Isaac Zacharias , a net sale of 27,000 shares made by Frank T Watkins , and a net sale of 2,172 shares made by Trinh Phung .

In summary, during the past 3 months, insiders sold 0 shares of Shockwave Medical Inc (SWAV) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 215,389 shares of Shockwave Medical Inc (SWAV) were sold and 0 shares were bought by its insiders, resulting in a net sale of 215,389 shares.

Shockwave Medical Inc (SWAV)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Shockwave Medical Inc Insider Transactions

No Available Data

Douglas Evan Godshall Mailing Address

Above is the net worth, insider trading, and ownership report for Douglas Evan Godshall. You might contact Douglas Evan Godshall via mailing address: Suite 4 Level 46 2 Park Street, Sidney C3 2000.